A Realist might say: the company is exactly what it looks like.

A company that has the licensing to sell a couple promising products in NA -once they are FDA approved. But the management is pathetic at running trials. One stalled at 20% enrollment- after years.. and the straigtforward 12 week trial- not even started after a year. 

That's it. That's the whole story. 

The lack of IR or even an Investor Update on their site is not some investing conspiracy - it's because they have zero good news to share.

The horrible share price and lack of volume reflect management's inability to accomplish straightforward trials.

The realist could also look at managemnet's questionable and desperate option moves- that look like stealing silverware from a sinking ship... but that's just piling on really.